Results 51 to 60 of about 636,342 (244)

DFT CALCULATED FOR VIBRATION FREQUENCIES AND IR ABSORPTION INTENSITIES OF [6] CYCLACENE (ARMCHAIR) MOLECULE [PDF]

open access: yesمجلة جامعة الانبار للعلوم الصرفة, 2012
تم حساب ترددات الاهتزاز وشدد امتصاص طیف الاشعة تحت الحمراء, لجمیع الاحداثیات الداخلیة لجزیئة [6] سایکلاسین نوع (Armchair) و بعددها 3N–6)) و مناقشتها تماثلیا و تأصریا وفق نظریة دوال الکثافة (DFT) وباسلوب (B3LYP) وعناصر قاعدة (6-311G).
REHAB M. KUBBA
doaj   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Improving Conductivity Image Quality Using Block Matrix-based Multiple Regularization (BMMR) Technique in EIT: A Simulation Study

open access: yesJournal of Electrical Bioimpedance, 2011
A Block Matrix based Multiple Regularization (BMMR) technique is proposed for improving conductivity image quality in Electrical Impedance Tomography (EIT).
Bera Tushar Kanti   +3 more
doaj   +1 more source

Presenting a Stock Market Model based on Risk Appetite, Investor Sentiment, and Monetary Policy Shock Using Smooth Transition Regression (STR) [PDF]

open access: yesراهبرد مدیریت مالی
This article seeks to provide a model to investigate the reaction of the stock market index, risk-taking and investors' sentiments to the monetary policy shock in the form of non-linear models.
Mohsen Hamidian   +2 more
doaj   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

CSYseq Y-STR mutation analysis.

open access: yes, 2021
A. Individual Y-STR mutation rates with their 95% CIs. The RM Y-STR treshold (10−2 mpg, dashed line) and average mutation rate (4.57×10−3 mpg, black line) are indicated. B.
Simon Vanpaemel (11401754)   +5 more
core   +1 more source

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

Screening for streptomycin resistance-conferring mutations in Mycobacterium tuberculosis clinical isolates from Poland. [PDF]

open access: yesPLoS ONE, 2014
Currently, mutations in three genes, namely rrs, rpsL, and gidB, encoding 16S rRNA, ribosomal protein S12, and 16S rRNA-specific methyltransferase, respectively, are considered to be involved in conferring resistance to streptomycin (STR) in ...
Tomasz Jagielski   +7 more
doaj   +1 more source

Proportions of different types of small variants in the STR and not in STR regions.

open access: yes, 2023
(a) The proportions of deletions, insertions, and SNVs in STR regions and (b) not in STR regions. The analysis was performed on high-confidence small variant sets from two individuals from the Platinum Genome and six individuals from GIAB. The numbers on
Ning Wang (108353)   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy